SMTL ID : 8ovz.1 (1 other biounit)

Crystal structure of D1228V c-MET bound by compound 16

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.21 Å

Oligo State

monomer

Ligands

10 x IOD: IODIDE ION(Non-functional Binders)

IOD.1: 2 residues within 4Å: Chain A: R.77, A.189 Ligand excluded by PLIP IOD.2: 2 residues within 4Å: Chain A: T.59, H.69 Ligand excluded by PLIP IOD.3: 1 residues within 4Å: Chain A: Y.157 Ligand excluded by PLIP IOD.4: 3 residues within 4Å: Chain A: K.281, P.291, R.299 Ligand excluded by PLIP IOD.5: 0 residues within 4Å: (No contacts) Ligand excluded by PLIP IOD.6: 3 residues within 4Å: Chain A: V.210, K.211, W.212 Ligand excluded by PLIP IOD.7: 2 residues within 4Å: Chain A: H.51, G.187 Ligand excluded by PLIP IOD.8: 4 residues within 4Å: Chain A: Q.86, M.192, Y.193, E.196 Ligand excluded by PLIP IOD.9: 3 residues within 4Å: Chain A: S.104, P.121, K.182 Ligand excluded by PLIP IOD.10: 3 residues within 4Å: Chain A: Y.193, D.194, K.195 Ligand excluded by PLIP

1 x W3N: 1-[(1S)-1-[3-(1H-imidazol-4-yl)phenyl]ethyl]-5-(1H-indazol-7-yl)pyrimidine-2,4-dione(Non-covalent)

W3N.11: 18 residues within 4Å: Chain A: K.73, F.87, E.90, G.91, M.94, V.102, L.103, L.105, I.108, V.118, L.120, F.163, H.165, V.183, A.184, D.185, A.189, R.190 17 PLIP interactions: 17 interactions with chain A Hydrophobic interactions: A:F.87, A:F.87, A:E.90, A:V.102, A:L.105, A:L.105, A:I.108, A:V.118, A:V.118 Hydrogen bonds: A:H.165, A:D.185, A:D.185, A:R.190, A:R.190 Water bridges: A:D.185, A:D.185 pi-Stacking: A:F.97

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Michaelides, I.N. et al., Discovery and Optimization of the First ATP Competitive Type-III c-MET Inhibitor. J.Med.Chem. (2023)

Release Date

2023-07-05

Peptides

Hepatocyte growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Hepatocyte growth factor receptor

Related Entries With Identical Sequence